Inola Drug is an authorized DME supplier for medicare equipments and products.
Inola Drug is a Community/Retail Pharmacy in Inola, Oklahoma. This pharmacy is owned and operated by Inola Drug Inc. It is located at 19 W Commercial St, Inola and it's customer support contact number is 918-543-8777. The authorized person of Inola Drug is Andrew Turner who is Pres Owner of the pharmacy and his contact number is 918-543-8777. Active license number of Inola Drug is 294353 for Community/Retail Pharmacy in Oklahoma. Inola Drug accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Inola Drug is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Inola Drug type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Inola Drug
Type:
Community/Retail Pharmacy
Location:
19 W Commercial St, Inola, Oklahoma, 74036-3606
Phone:
918-543-8777
Fax:
918-543-2013
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Andrew Turner
Position:
Pres Owner
Contact Number:
918-543-8777
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1487722211
NPI Enumeration Date:
01 Dec, 2006
NPI Last Update On:
12 Jun, 2015
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Inola Drug are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
294353
Oklahoma
Primary
Durable Medical Equipment & Medical Supplies
Secondary
Compounding Pharmacy
Secondary
Long Term Care Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
100236740A
Medicaid
Oklahoma
2076233
Other
Pk
Medicare Enrollment:
Inola Drug is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
7113044710
O20100930033264
Inola Drug Inc
DME SUPPLIER - PHARMACY
7113044710
O20160726000676
Inola Drug Inc
PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY)
Products Available:
Inola Drug has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Custom Fabricated
Nebulizer Equipment & Supplies
Orthoses: Off-the-shelf
Ostomy Supplies
Surgical Dressings
Urological Supplies
Walkers
Wheelchair Seating/cushions
Wheelchairs & Accessories: Standard Manual
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 700, Inola, Oklahoma
Zip:
74036-0700
Phone Number:
--
Fax Number:
--
Patients can reach Inola Drug at 19 W Commercial St, Inola, Oklahoma or can call on customer care at 918-543-8777.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.